
Supporting clinical trials for Myeloma treatment
We understand this disease much better than before, and treatments have improved remarkably over the past 15 years – patients are living twice as long as they used to, and their quality of life is also much improved. It's also exciting for when we finally reach the point where we can tailor treatments to individuals based on their genetic make-up – reduce the trial and error associated with going through the standard drug regimens.